CGTX (CGTX) Stock Price & Analysis
CGTX (CGTX) fell 1.91% to USD 1.03 as of September 8, 2026 at 12:46 UTC, according to Nexqual real-time market data.
CGTX last closed at USD 1.03; the session ranged USD 1.01–1.05 on volume of 377,466 shares. Market capitalization is —, with a 52-week range of USD 0.55–2.6 (NCM). Source: Nexqual, September 8, 2026 at 12:46 UTC.
Key Statistics (as of September 8, 2026 at 12:46 UTC)
| Price | USD 1.03 |
|---|---|
| Change | ▼ 1.91% (down) |
| Previous Close | USD 1.03 |
| Open | USD 1.03 |
| Day Range | USD 1.01 – 1.05 |
| 52-Week Range | USD 0.55 – 2.6 |
| Volume | 377,466 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CGTX)
Nexqual's technical model rates CGTX "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 12:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.79 (neutral) |
| vs SMA50 | Above (USD 1.02) |
| MACD | 0 (positive) |
From CGTX's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INAB | IN8bio, Inc. | USD 1.2 | ▲ 9.09% |
| XPON | Expion Energy, Inc. | USD 5.86 | ▼ 3.62% |
| SPRC | SciSparc Ltd. | USD 5.29 | ▼ 9.57% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0% |
| UNCY | Unicycive Therapeutics, Inc. | USD 5.16 | ▼ 0.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:46 UTC. This page is informational and not investment advice.